Health Care Industry
Industry: Email Alert RSS FeedNIAID Describes Research Priorities to Fight Drug-Resistant Tuberculosis
National Institutes of Health: News and Events, April 22, 2008
<?xml version="1.0" encoding="ISO-8859-1"?>
<!DOCTYPE text PUBLIC "-//The Gale Group//DTD Mercury Version 1.0//EN" "Article.dtd">
- Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »
<Text rich="yes"> <P> Tuberculosis (TB) has long been one of the world ' s great killers. Now, forms of drug-resistant TB-multidrug (MDR) and extensively drug-resistant (XDR)-are occurring at an ominous and accelerating rate. To help in the fight against drug-resistant TB, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has formulated an MDR and XDR TB research agenda. </P> <XEB.p> To read the full text of this article, click here: <XEB.a href="http://www.nih.gov/news/health/apr2008/niaid-22.htm" style="external"> http://www.nih.gov/news/health/apr2008/niaid-22.htm </XEB.a> </XEB.p> </Text>
COPYRIGHT 2008 National Institutes of Health
COPYRIGHT 2008 Gale, Cengage Learning